Good News for Rare Disease Day and Every Day: Promising Lead on New Treatment for Pseudomyxoma Peritonei (PMP) — Written by: Deborah Shelton, ACPMP Executive Director

February 24, 2022

ACPMP Executive Director, Deborah Shelton, has over 25 years of experience providing regulatory advice to a diverse group of stakeholders navigating the complex landscape of scientific and clinical research directed at the development of treatments for cancer and a wide range of other conditions, with a particular focus on rare diseases. In research funded with grant support from the ACPMP Research...